-

Eurofins: Purchases of Own Shares From April 22nd to April 25th 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins (Paris:ERF):

Name of the Issuer

Identity code of the Issuer

Day of the transaction

Identity code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC Code)

EUROFINS

529900JEHFM47DYY3S57

22/03/2025

FR0014000MR3

88,000

49.0621

XPAR

EUROFINS

529900JEHFM47DYY3S57

22/03/2025

FR0014000MR3

54,000

49.0614

CEUX

EUROFINS

529900JEHFM47DYY3S57

22/03/2025

FR0014000MR3

4,000

49.0546

TQEX

EUROFINS

529900JEHFM47DYY3S57

22/03/2025

FR0014000MR3

4,000

49.0547

AQEU

EUROFINS

529900JEHFM47DYY3S57

23/03/2025

FR0014000MR3

102,000

54.3427

XPAR

EUROFINS

529900JEHFM47DYY3S57

23/03/2025

FR0014000MR3

40,000

54.5934

CEUX

EUROFINS

529900JEHFM47DYY3S57

23/03/2025

FR0014000MR3

4,000

54.5670

TQEX

EUROFINS

529900JEHFM47DYY3S57

23/03/2025

FR0014000MR3

4,000

54.5674

AQEU

EUROFINS

529900JEHFM47DYY3S57

24/03/2025

FR0014000MR3

75,000

54.2322

XPAR

EUROFINS

529900JEHFM47DYY3S57

24/03/2025

FR0014000MR3

20,000

54.2591

CEUX

EUROFINS

529900JEHFM47DYY3S57

24/03/2025

FR0014000MR3

2,500

54.2587

TQEX

EUROFINS

529900JEHFM47DYY3S57

24/03/2025

FR0014000MR3

2,500

54.2716

AQEU

EUROFINS

529900JEHFM47DYY3S57

25/03/2025

FR0014000MR3

70,000

54.2848

XPAR

EUROFINS

529900JEHFM47DYY3S57

25/03/2025

FR0014000MR3

22,000

54.2751

CEUX

EUROFINS

529900JEHFM47DYY3S57

25/03/2025

FR0014000MR3

4,000

54.2834

TQEX

EUROFINS

529900JEHFM47DYY3S57

25/03/2025

FR0014000MR3

4,000

54.2887

AQEU

 

 

 

TOTAL

500,000

52.7493

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins

Eurofins

BOURSE:ERF
Release Versions
English

Contacts

Eurofins

More News From Eurofins

Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples

LYON, France--(BUSINESS WIRE)--Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples. This innovation underlines Eurofins Biomnis’ diagnostic innovation, and its commitment to contributing its expert...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd March to 06th March 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 30 000 67.7739 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 10 000 67.7248 CEUX EUROFINS SCIENTIFIC 529900JEHFM...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE – E1013 2. Identi...
Back to Newsroom